| Title |
Cognitive enhancement following acute losartan in normotensive young adults
|
|---|---|
| Published in |
Psychopharmacology, April 2011
|
| DOI | 10.1007/s00213-011-2257-9 |
| Pubmed ID | |
| Authors |
Rasha Mechaeil, Paul Gard, Anne Jackson, Jennifer Rusted |
| Abstract |
Losartan, an angiotensin II receptor antagonist (AIIA), is an antihypertensive that has previously been suggested to have cognitive-enhancing potential for older adults. The objective indices for such effects are equivocal, however, and if these drugs do offer dual advantages of hypertension control plus cognitive-enhancing potential, there exists a clear need to establish this directly. |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Australia | 1 | 50% |
| Unknown | 1 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Practitioners (doctors, other healthcare professionals) | 1 | 50% |
| Members of the public | 1 | 50% |
Mendeley readers
The data shown below were compiled from readership statistics for 86 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 2 | 2% |
| United States | 1 | 1% |
| South Africa | 1 | 1% |
| Unknown | 82 | 95% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 11 | 13% |
| Student > Bachelor | 10 | 12% |
| Researcher | 9 | 10% |
| Student > Ph. D. Student | 8 | 9% |
| Other | 7 | 8% |
| Other | 15 | 17% |
| Unknown | 26 | 30% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 20 | 23% |
| Psychology | 16 | 19% |
| Neuroscience | 6 | 7% |
| Agricultural and Biological Sciences | 3 | 3% |
| Sports and Recreations | 2 | 2% |
| Other | 9 | 10% |
| Unknown | 30 | 35% |
Attention Score in Context
This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 December 2014.
All research outputs
#6,157,585
of 23,177,498 outputs
Outputs from Psychopharmacology
#1,773
of 5,379 outputs
Outputs of similar age
#34,100
of 109,898 outputs
Outputs of similar age from Psychopharmacology
#12
of 31 outputs
Altmetric has tracked 23,177,498 research outputs across all sources so far. This one has received more attention than most of these and is in the 73rd percentile.
So far Altmetric has tracked 5,379 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.7. This one has gotten more attention than average, scoring higher than 66% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 109,898 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 68% of its contemporaries.
We're also able to compare this research output to 31 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 61% of its contemporaries.